<DOC>
	<DOCNO>NCT00331669</DOCNO>
	<brief_summary>The purpose randomize , double blind , multi-center study assess efficacy safety bilateral pallidal deep brain stimulation patient tardive dystonia .</brief_summary>
	<brief_title>Efficacy Safety Deep Brain Stimulation ( DBS ) Pallidal ( GPi ) Patients With Tardive Dystonia</brief_title>
	<detailed_description>Deep brain stimulation ( DBS ) establish new reversible , neurosurgical therapeutic option patient suffer disable neurological movement disorder essential tremor ParkinsonÂ´s disease . Recently , deep brain stimulation successfully applied patient primary generalized segmental dystonia . Additionally , number case report suggest pallidal deep brain stimulation may also improve tardive dystonia , may instance result intake neuroleptic notoriously difficult treat medically . The present study investigate effect pallidal DBS use double blind , randomize design ( sham- versus verum-stimulation within 3-months interval post implantation electrode ) . Initially 60 patient calculated power analysis ass significant result base average improvement dystonic symptom 30 % . However , recent study ( Damier et al. , Archives General Psychiatry , 2007 ) , 10 10 show successful outcome approximately 50 % decrease extrapyramidal symptom rating scale score . The exact one- side low 95 % confidence limit would 0.794 result . If approach choose sample size estimation 18 verum 18 placebo patient one would obtain power 82 % placebo effect 30 % success rate . For placebo effect 25 % one need 16+16 patient placebo effect 20 % one need 12+12 patient . We thus decide reduce sample size 36- 32- 24 patient . It expect continuous primary outcome measure preserve even high power binary one use study mention . The local ethical committee approve .</detailed_description>
	<mesh_term>Dystonia</mesh_term>
	<mesh_term>Dystonic Disorders</mesh_term>
	<mesh_term>Movement Disorders</mesh_term>
	<criteria>Operational criterion tardive dystonia &gt; 18 month cessation neuroleptic exposure 1875 year Relevant functional impairment daily living activity BFMDRS &gt; 8 AIMS &gt; 16 Informed write consent PANNS &gt; 60 ( Schizophrenia ) HamiltonScore &gt; 18 ( Depression ) MATTISScore &lt; 120 ( Dementia ) Preceding stereotactic neurosurgery Pronounced brain atrophy Increased bleed risk Decreased immune status Botulinum Toxin treatment within last 3 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>deep brain stimulation</keyword>
	<keyword>pallidum</keyword>
	<keyword>tardive dystonia</keyword>
	<keyword>randomize</keyword>
	<keyword>double blind</keyword>
	<keyword>multicenter</keyword>
</DOC>